Risheng Chemical Announces Board Approval of Consolidated Financial Report for Q2 115

Release Date: 115/08/08 Statement Date: 115/08/07 Statement Time: 16:13:48 Company Code: 1735 Company Name: Risheng Chemical Subject: Announcement of Board Approval of Consolidated Financial Report for Q2 115 Applicable Clause: Item 31 Event Date: 115/08/07 Details: 1. Date reported to or approved by the board of directors: 115/08/07 2. Audit Committee approval date: 115/08/07 3. Reporting period for financial report or self-compiled annual financial information (start ~ end): 115/01/01 ~ 115/06/30 4. Cumulative operating revenue from January 1 to current period (in thousand NT$): 1,263,331 5. Cumulative operating profit (loss) from January 1 to current period (in thousand NT$): 240,997 6. Cumulative operating income (loss) from January 1 to current period (in thousand NT$): 62,070 7. Cumulative pre-tax net profit (loss) from January 1 to current period (in thousand NT$): 53,992 8. Cumulative net profit (loss) for the period from January 1 to current period (in thousand NT$): 38,861 9. Cumulative net profit (loss) attributable to owners of parent from January 1 to current period (in thousand NT$): 38,861 10. Cumulative basic earnings (loss) per share from January 1 to current period (in NT$): 0.39 11. Total assets at end of period (in thousand NT$): 3,100,370 12. Total liabilities at end of period (in thousand NT$): 1,558,832 13. Equity attributable to owners of parent at end of period (in thousand NT$): 1,541,538 14. Other matters to be disclosed: None